Harmony Biosciences Holdings (HRMY) Cash from Investing Activities (2019 - 2026)

Harmony Biosciences Holdings has disclosed Cash from Investing Activities across 8 years of filings, most recently posting -$183.6 million for Q1 2026.

• Cash from Investing Activities for Q1 2026 came in at -$183.6 million, down 7875.02% year-over-year; the trailing twelve-month figure through Mar 2026 was -$225.7 million (down 282.88% YoY), and the FY2025 annual result was -$39.6 million, up 41.25% from the prior year.
• Cash from Investing Activities came in at -$183.6 million for Q1 2026 at Harmony Biosciences Holdings, down from -$17.6 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $2.4 million in Q1 2025 to a low of -$183.6 million in Q1 2026.
• The 5-year median for Cash from Investing Activities is -$17.6 million (2025), against an average of -$28.2 million.
• Across the five-year window, Cash from Investing Activities plunged 34787.1% in 2022 and soared 191.64% in 2024, its largest moves.
• Harmony Biosciences Holdings' Cash from Investing Activities stood at -$46.9 million in 2022, then increased by 23.09% to -$36.1 million in 2023, then soared by 80.07% to -$7.2 million in 2024, then sank by 145.35% to -$17.6 million in 2025, then tumbled by 941.49% to -$183.6 million in 2026.
• The last three Cash from Investing Activities figures came in at -$183.6 million (Q1 2026), -$17.6 million (Q4 2025), and -$4.8 million (Q3 2025), per Business Quant data.